China Pharma Holdings, Inc. (CPHI) Stock Overview
Explore China Pharma Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.
China Pharma Holdings, Inc. (CPHI)
Key Financials
Key Financials
Market Cap
42.5M
P/E Ratio
-0.97
EPS (TTM)
$-0.64
ROE
-0.17%
CPHI Stock Analysis & Investment Overview (AMEX)
Our AI-powered analysis of China Pharma Holdings, Inc. (AMEX: CPHI) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, China Pharma Holdings, Inc.'s AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of CPHI on the AMEX shows an RSI of 47.11, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.68 for the AMEX listing.
Key metrics behind China Pharma Holdings, Inc.'s AMEX-traded stock include a P/E ratio of -0.97 and a market capitalization of 42.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CPHI on the AMEX.